Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Aripiprazole | HCID 60795 | — |
| Reactant | Pivaloyl chloride | HCID 62493 | — |
| Catalyst | Aripiprazole | HCID 60795 | — |
| Solvent | Pyridine | HCID 1049 | — |
| Product | HCID 58579118 | HCID 58579118 | 501.1% |
Reaction Steps
To a stirred solution of aripiprazole (0.1 g, 0.223 mmol) in pyridine (1 mL) at 0° C. was added pivaloyl chloride (0.055 mL, 0.446 mmol). After stirring at 0° C. for 5 minutes the reaction was allowed to warm to room temperature. After a further 5 minutes the temperature was increased to 50° C. for approximately 19 hours. The reaction was allowed to cool to room temperature. The reaction was repeated in a similar manner using of aripiprazole (1.75 g, 3.90 mmol). The two reaction mixtures were combined and quenched with approximately methanol (5 mL). The majority of the pyridine was removed in vacuo and the residue partitioned between dichloromethane (30 mL) and saturated NaHCO3 solution (30 mL). The aqueous phase was extracted with dichloromethane (2×30 mL) and the combined organic extracts washed with brine (20 mL) and dried over MgSO4. After filtration, the volatiles were removed (toluene and methanol/dichloromethane azeotrope) and the residue purified by silica chromatography eluting first with dichloromethane followed by ethyl acetate/dichloromethane/methanol (1:1:0.04) to give the title compound (1.19 g, 54%).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US09072788B2 |
|---|
| Source dataset | uspto-grants-2015_07 |
|---|
| ORD ID | ord-e5b93531abba434288b685171e84abd3 |
|---|
| Source note | uspto-grants-2015_07 |
|---|